The 2022 AACR Meeting delivered a significant amount of new data and analysis regarding numerous drugs and clinical trials within the cytokine space. At Beacon, we have extracted all the key data, updated our database, and put it into a downloadable report.
Summary insights for cytokine-related abstracts at AACR 2022:
- A total of 128 cytokine-related abstracts were identified
- 72% Of the 128 abstracts contained preclinical data
- The two most common cytokine targets are IL-2 and IL-15
- Interleukins were the dominant cytokine class in fusion proteins
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements